Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Deschanvres

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study'-author's replyRaphaël Lecomte, Colin Deschanvres, Sandrine Coudol, et al.
The Journal of Infection|August 10, 2020
Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?Gabriel Birgand, Karine Blanckaert, Colin Deschanvres, et al.
Jac-Antimicrobial Resistance|April 3, 2023
Expert consensus on monitoring antimicrobial stewardship in French nursing homes using assessed reimbursement database indicatorsAntoine Asquier-Khati, Colin Deschanvres, Anicet Chaslerie, et al.
Antimicrobial Resistance and Infection Control|March 30, 2021
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational studyColin Deschanvres, Thomas Haudebourg, Nathan Peiffer-Smadja, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2026
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world studyThomas Drumel, Julie Kimmerlin, Clotilde Allavena, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2019
Population Pharmacokinetic Study of Cefazolin Dosage Adaptation in Bacteremia and Infective Endocarditis Based on a NomogramRonan Bellouard, Colin Deschanvres, Guillaume Deslandes, et al.
Future Microbiology|December 13, 2016
Daptomycin use: where is the truth?Guillaume Ghislain Aubin, Colin Deschanvres, David Boutoille, et al.
Vaccine|December 2, 2022
Non-immunization associated with increased risk of sudden unexpected death in infancy: A national case-control studyColin Deschanvres, Karine Levieux, Elise Launay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced personsThomas Drumel, Justine Sourice, Clotilde Allavena, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2018
High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related <i>Staphylococcus aureus</i> VentriculitisMatthieu Grégoire, Benjamin Gaborit, Colin Deschanvres, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study'-author's replyRaphaël Lecomte, Colin Deschanvres, Sandrine Coudol, et al.
The Journal of Infection|August 10, 2020
Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?Gabriel Birgand, Karine Blanckaert, Colin Deschanvres, et al.
Jac-Antimicrobial Resistance|April 3, 2023
Expert consensus on monitoring antimicrobial stewardship in French nursing homes using assessed reimbursement database indicatorsAntoine Asquier-Khati, Colin Deschanvres, Anicet Chaslerie, et al.
Antimicrobial Resistance and Infection Control|March 30, 2021
How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational studyColin Deschanvres, Thomas Haudebourg, Nathan Peiffer-Smadja, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2026
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world studyThomas Drumel, Julie Kimmerlin, Clotilde Allavena, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2019
Population Pharmacokinetic Study of Cefazolin Dosage Adaptation in Bacteremia and Infective Endocarditis Based on a NomogramRonan Bellouard, Colin Deschanvres, Guillaume Deslandes, et al.
Future Microbiology|December 13, 2016
Daptomycin use: where is the truth?Guillaume Ghislain Aubin, Colin Deschanvres, David Boutoille, et al.
Vaccine|December 2, 2022
Non-immunization associated with increased risk of sudden unexpected death in infancy: A national case-control studyColin Deschanvres, Karine Levieux, Elise Launay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced personsThomas Drumel, Justine Sourice, Clotilde Allavena, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2018
High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related <i>Staphylococcus aureus</i> VentriculitisMatthieu Grégoire, Benjamin Gaborit, Colin Deschanvres, et al.
Pageof 3